
Profitability, historical returns, and peer comparisons.
According to BioCryst Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 101.55%. This represents a change of -520.59% compared to the average of -24.15% of the last 4 quarters.
The mean historical ROE of BioCryst Pharmaceuticals, Inc. over the last ten years is 80.13%. The current 101.55% ROE has changed 26.74% with respect to the historical average. Over the past ten years (40 quarters), BCRX's ROE was at its highest in in the June 2019 quarter at 409.32%. The ROE was at its lowest in in the March 2020 quarter at -1030.67%.
Average
80.13%
Median
16.25%
Minimum
-284.68%
Maximum
949.09%
Discovering the peaks and valleys of BioCryst Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 32.87%
Maximum Annual ROE = 949.09%
Minimum Annual Increase = -2158.03%
Minimum Annual ROE = -284.68%
| Year | ROE | Change |
|---|---|---|
| 2025 | -221.45% | -1285.79% |
| 2024 | 18.68% | -62.45% |
| 2023 | 49.73% | -40.71% |
| 2022 | 83.88% | -51.24% |
| 2021 | 172.04% | -81.87% |
| 2020 | 949.09% | -433.39% |
| 2019 | -284.68% | -2158.03% |
| 2018 | 13.83% | 32.87% |
| 2017 | 10.41% | 6.87% |
| 2016 | 9.74% | 15.70% |
The current ROE of BioCryst Pharmaceuticals, Inc. (BCRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-51.01%
5-year avg
20.58%
10-year avg
80.13%
BioCryst Pharmaceuticals, Inc.’s ROE is greater than Atea Pharmaceuticals, Inc. (-64.25%), greater than Pharvaris N.V. (-61.24%), greater than Vir Biotechnology, Inc. (-29.99%),
| Company | ROE | Market cap |
|---|---|---|
| -64.25% | $324.04M | |
| -61.24% | $2.32B | |
| -29.99% | $1.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioCryst Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioCryst Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioCryst Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for BioCryst Pharmaceuticals, Inc. (BCRX)?
What is the highest ROE for BioCryst Pharmaceuticals, Inc. (BCRX)?
What is the 3-year average ROE for BioCryst Pharmaceuticals, Inc. (BCRX)?
What is the 5-year average ROE for BioCryst Pharmaceuticals, Inc. (BCRX)?
How does the current ROE for BioCryst Pharmaceuticals, Inc. (BCRX) compare to its historical average?